Drugs that contain Sotalol Hydrochloride
1. Sotalol Hydrochloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10512620 | ALTATHERA PHARMS LLC | Method of initiating and escalating sotalol hydrochloride dosing |
Aug, 2038
(14 years from now) | |
| US11696902 | ALTATHERA PHARMS LLC | Method of initiating and escalating sotalol hydrochloride dosing |
Aug, 2038
(14 years from now) | |
| US10799138 | ALTATHERA PHARMS LLC | Method of administering sotalol IV/switch |
Apr, 2039
(14 years from now) | |
| US11583216 | ALTATHERA PHARMS LLC | Method of administering sotalol IV/switch |
Aug, 2039
(15 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Jul 02, 2016 |
Market Authorisation Date: 02 July, 2009
Treatment: Intravenous sotalol dosing regimen for achieving steady state exposure in a facility that can provide electrocardiographic monitoring; Dosing regimen for intravenous sotalol for administration in a fa...
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
SOTALOL HYDROCHLORIDE family patents
2. Sotylize patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11013703 | AZURITY | Sotalol compositions and uses of the same |
Apr, 2034
(9 years from now) | |
| US10206895 | AZURITY | Sotalol compositions and uses of the same |
Apr, 2034
(9 years from now) | |
| US11850222 | AZURITY | Sotalol compositions and uses of the same |
Nov, 2034
(10 years from now) | |
| US9724297 | AZURITY | Sotalol compositions and uses of the same |
Aug, 2035
(11 years from now) | |
Market Authorisation Date: 22 October, 2014
Treatment: Indicated for the treatment of ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgement of the physician are life-threatening; Sotylize is indicated for the maintenanc...
Dosage: SOLUTION;ORAL
More Information on Dosage
SOTYLIZE family patents